No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
546 |
4. Check minimum number of eventsNone |
546 |
5. Include endpointsNone |
546 |
6. Filter based on genotype QC (FinnGen only) |
546 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H81
- Name in latin
- Vertigo centralis
Similar endpoints
↥List of similar endpoints to
Vertigo of central origin
based on the number of shared cases.
Similar with more cases:
- Disorders of vestibular function (Vertigo)
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4801 | 3024 | 1740 |
| Only index persons | 3769 | 2372 | 1397 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.09 | 0.05 |
| Only index persons | 0.07 | 0.09 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 70.36 | 71.94 | 67.46 |
| Only index persons | 66.62 | 67.92 | 64.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 546 | 325 | 221 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.10 |
| Median age at first event (years) | 62.07 | 60.16 | 64.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 499
- Matched controls
- 4988
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H81.4
ICD-10 Finland
Vertigo of central origin
4503599627370496.0
323.0
498
7
R42
ICD-10 Finland
Dizziness and giddiness
13.8
149.1
339
663
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
12.5
60.6
115
117
H81.3
ICD-10 Finland
Other peripheral vertigo
49.8
57.5
69
16
DFF59
NOMESCO Finland
Other assessment of balance
126.4
43.5
46
*
AA1AD
NOMESCO Finland
CT of head and brain
3.8
37.3
207
786
H81.2
ICD-10 Finland
Vestibular neuronitis
372.0
35.4
35
*
N07CA01
ATC
betahistine; oral
6.2
32.0
93
179
H81.0
ICD-10 Finland
Ménière disease
42.3
22.9
28
7
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.1
22.6
76
171
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.3
21.5
69
147
DFF00
NOMESCO Finland
Pure tone audiometry
4.1
19.5
81
225
N17
ICPC
Vertigo/dizziness
3.5
18.6
94
308
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.8
17.8
62
144
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.2
16.5
95
341
SPAT1263
SPAT
Sampling
2.2
14.8
238
1482
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
43.8
14.2
17
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.3
13.3
70
235
R51.80
ICD-10 Finland
Headache
2.8
13.1
89
354
SPAT1216
SPAT
Assessment of functional ability
2.5
12.7
111
510
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
12.5
117
556
DFF50
NOMESCO Finland
Electronystagmography
133.2
12.5
13
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
12.0
92
392
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
12.0
169
975
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.3
11.5
30
50
N02AX02
ATC
tramadol; systemic, rectal
2.0
11.5
233
1546
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.2
11.3
60
202
T90.5
ICD-10 Finland
Sequelae of intracranial injury
20.6
11.2
16
8
H02AB04
ATC
methylprednisolone; systemic
2.5
10.9
93
418
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
10.2
236
1614
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.2
10.2
111
565
N03AX16
ATC
pregabalin; oral
2.1
10.1
138
776
UDC00
NOMESCO Finland
Ear microscopy
3.4
10.0
49
156
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
9.9
105
525
N05AB04
ATC
prochlorperazine; systemic, rectal
5.2
9.9
30
61
R11
ICD-10 Finland
Nausea and vomiting
3.0
9.9
57
204
S06.0
ICD-10 Finland
Concussion
2.8
9.7
64
250
M01AE02
ATC
naproxen; oral, rectal
1.8
9.6
273
1989
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
9.6
101
503
R53
ICD-10 Finland
Malaise and fatigue
2.1
9.6
128
712
G44.2
ICD-10 Finland
Tension-type headache
2.5
9.5
76
331
B01AC07
ATC
dipyridamole; systemic
3.1
9.3
50
171
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
9.3
120
656
A02BC02
ATC
pantoprazole; systemic
1.8
9.2
326
2541
UKC02
NOMESCO Finland
Cystoscopy
2.2
9.2
103
530
N03AE01
ATC
clonazepam; systemic
3.5
9.2
42
127
A02BC05
ATC
esomeprazole; systemic
1.8
9.1
215
1466
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.6
8.9
30
69
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.7
8.8
38
110
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
3.5
8.8
40
121
M03BX02
ATC
tizanidine; oral
1.8
8.7
280
2095
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
8.7
80
374
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
8.7
147
890
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.9
8.6
53
198
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
8.5
161
1014
H02AB07
ATC
prednisone; oral
2.3
8.5
84
407
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
7.6
8.5
19
26
SPAT1229
SPAT
Assessment of need for aid
2.7
8.3
59
239
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.3
8.3
19
27
TAB00
NOMESCO Finland
Lumbar puncture
4.0
8.3
32
84
N06AX11
ATC
mirtazapine; oral
1.8
8.2
160
1014
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.6
8.2
35
101
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
7.9
77
368
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
7.9
56
227
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
7.6
7.7
17
23
P76
ICPC
Depressive disorder
3.5
7.6
34
102
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
7.5
95
512
J37.0
ICD-10 Finland
Chronic laryngitis
4.7
7.5
24
53
DAX08
NOMESCO Finland
Fitting of hearing aid
3.4
7.5
35
109
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
7.8
7.4
16
21
SPAT1097
SPAT
Recording of ECG
2.1
7.4
89
469
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
7.4
170
1129
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
7.4
87
455
M54.5
ICD-10 Finland
Low back pain
1.8
7.4
160
1045
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
7.3
31
89
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.2
7.3
26
64
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.8
7.3
23
50
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
7.3
46
175
H25.8
ICD-10 Finland
Other senile cataract
2.1
7.3
82
422
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.1
7.2
38
129
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
7.2
171
1144
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
7.2
102
572
J01DA01
ATC
[U] cefalexin; systemic
1.7
7.1
302
2389
NH1AD
NOMESCO Finland
Ankle and foot CT
6.5
7.0
17
27
H82
ICPC
Vertiginous syndrome
5.6
7.0
19
35
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.9
7.0
27
72
H53.2
ICD-10 Finland
Diplopia
4.5
6.9
23
53
A04
ICPC
Weakness/tiredness general
2.2
6.9
75
376
L28
ICPC
Limited function/disability (L)
2.0
6.9
98
550
N05BA12
ATC
alprazolam; oral
2.4
6.9
60
274
H53.1
ICD-10 Finland
Subjective visual disturbances
3.1
6.9
36
122
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
6.9
44
169
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
6.9
110
648
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.7
420
3689
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.8
6.6
42
161
SPAT1312
SPAT
General health counselling
1.8
6.6
145
946
G35
ICD-10 Finland
Multiple sclerosis
7.0
6.6
15
22
R03BA05
ATC
fluticasone; inhalant
1.9
6.5
95
537
N03AF02
ATC
oxcarbazepine; oral
4.4
6.5
22
52
SPAT1254
SPAT
Administration of medicine
2.0
6.5
88
487
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.5
6.5
48
200
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.8
6.5
20
43
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
70.7
6.4
7
*
SPAT1104
SPAT
Monitoring of emergency patient
2.6
6.3
44
177
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
6.3
190
1356
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
6.3
55
250
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
6.3
25
69
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.3
6.3
30
96
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
7.2
6.3
14
20
J01DB01
ATC
cefalexin; oral
1.7
6.2
381
3266
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
6.2
57
265
R51
ICD-10 Finland
Headache
3.2
6.2
30
97
N99
ICPC
Neurological disease other
7.8
6.2
13
17
G47.3
ICD-10 Finland
Sleep apnoea
1.9
6.1
101
600
N05CF01
ATC
zopiclone; oral
1.7
6.1
172
1203
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
6.1
55
256
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
6.1
134
872
N03AX09
ATC
lamotrigine; oral
3.8
6.1
24
66
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
6.0
42
168
M01AB51
ATC
indometacin, combinations; oral, rectal
4.7
6.0
19
42
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.0
79
431
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.3
6.0
28
88
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013512) EKG study
290
1313
3.58
47.51
5.7
4.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
165
539
3.96
43.96
5.0
4.6
%
32.7
32.2
0.24
109
358
(3019225) pH of Specimen
138
439
3.87
37.66
5.2
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
309
1754
2.76
29.57
5.1
3.9
ng/l
37.9
56.4
0.44
247
1296
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
69
182
4.20
23.91
4.7
4.0
mmol/l
24.5
25.1
1.24
63
172
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
87
272
3.62
23.70
4.0
3.5
mmol/l
0.9
1.9
1.18
63
210
(3009343) pH of Capillary blood
89
291
3.46
22.59
4.0
3.4
ph
7.4
7.4
—
6
27
(3013826) Glucose [Moles/volume] in Serum or Plasma
378
2567
2.54
22.23
4.8
4.5
mmol/l
6.8
6.7
0.13
355
2400
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
244
1366
2.42
22.15
2.3
2.1
u/l
135.2
247.1
1.28
231
1284
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
89
295
3.41
22.09
4.0
3.3
kpa
5.1
5.1
0.01
82
272
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
65
180
3.96
21.02
2.2
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
82
281
3.26
19.19
2.8
3.3
e9/l
3.7
4.1
0.73
50
210
(3032080) INR in Blood by Coagulation assay
295
1873
2.25
19.08
11.7
9.5
inr
1.4
1.3
0.60
54
528
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
60
168
3.89
19.07
2.0
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
69
224
3.38
17.57
4.5
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
396
2935
2.28
16.28
6.6
4.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
1461
2.13
16.23
3.2
3.1
ng/l
1143.9
1520.4
1.37
193
1248
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
357
2586
2.10
14.88
4.0
3.1
u/l
55.2
48.7
0.52
322
2393
(42870588) Differential panel, method unspecified - Blood
228
1408
2.06
14.71
7.0
5.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
63
5.16
14.69
1.2
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
278
1897
1.95
13.04
2.3
2.0
pmol/l
104.0
95.4
1.58
162
980
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
217
1362
1.99
13.00
3.1
2.4
u/l
58.1
56.6
0.11
195
1261
(4024509)
20
30
6.88
12.83
1.9
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
167
965
2.05
12.54
1.9
1.7
nmol/l
1053.9
1186.4
0.88
110
720
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
23
7.60
11.90
1.1
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
311
2245
1.90
11.90
6.7
6.4
mmol/l
1.2
1.2
0.80
253
1896
(3018010) Neutrophils/100 leukocytes in Blood
281
1976
1.87
11.54
5.9
5.5
%
57.5
57.8
0.16
247
1842
(3002030) Lymphocytes/100 leukocytes in Blood
284
2005
1.87
11.51
6.8
5.7
%
27.2
27.0
0.15
246
1859
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
57
4.74
11.29
2.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
57
4.74
11.29
2.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
58
4.66
11.06
2.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
399
3174
1.96
10.82
5.5
4.1
mm/h
13.5
13.0
0.26
361
2906
(3008757) Leukocyte morphology finding [Identifier] in Blood
25
55
4.72
10.82
7.5
3.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
276
1966
1.82
10.55
7.2
5.8
%
8.4
8.7
0.66
244
1839
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
65
4.32
10.47
1.7
2.9
mg/l
43.0
28.0
—
8
19
(3006504) Eosinophils/100 leukocytes in Blood
275
1960
1.81
10.46
6.6
5.5
%
2.7
2.8
0.46
240
1819
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
255
1778
1.82
10.42
2.5
2.3
nmol/l
80.4
77.8
0.72
215
1574
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
31
5.97
10.12
1.9
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
31
5.97
10.12
1.9
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
210
1391
1.83
10.08
2.7
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
281
2039
1.78
9.86
5.8
5.6
mmol/l
1.2
1.2
0.89
232
1840
(3037121) Protein [Mass/volume] in Urine
43
149
3.05
9.78
3.6
2.9
g/l
0.3
0.2
0.27
11
48
(3021960) Folate [Moles/volume] in Serum or Plasma
179
1140
1.85
9.68
1.7
1.6
nmol/l
20.8
20.8
0.01
144
963
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
68
301
2.44
9.66
1.9
1.6
—
—
—
0
0
(4146454)
20
40
5.15
9.64
2.3
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
168
1053
1.86
9.53
2.7
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
18
33
5.61
9.51
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
23
6.68
9.39
2.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
23
6.68
9.39
2.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
12
9.33
9.00
5.2
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
51
4.45
8.94
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
180
1173
1.80
8.90
2.5
2.1
mg/l
3.1
3.2
0.05
144
997
(3022096) Basophils/100 leukocytes in Blood
261
1905
1.71
8.56
6.7
5.5
%
0.7
0.7
0.20
228
1768
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
479
4193
2.18
8.24
20.6
15.2
mg/l
17.8
24.5
6.39
417
3341
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
58
258
2.40
8.14
2.6
2.5
—
17.1
—
0
10
(3031040) Bacteria [#/volume] in Urine by Automated count
356
2853
1.71
8.04
7.2
4.8
e6/l
34.7
4643.7
—
6
60
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
388
3193
1.75
7.86
4.9
4.0
pmol/l
15.3
14.9
2.35
335
2854
(3036481) Cortisol [Moles/volume] in Serum or Plasma
78
400
2.11
7.79
2.1
1.8
nmol/l
367.9
382.4
0.23
63
357
(3023520) Reticulocytes [#/volume] in Blood
79
411
2.08
7.59
2.2
2.6
e9/l
61.5
71.7
3.36
66
322
(3016018) Differential panel - Cerebral spinal fluid
14
25
5.72
7.58
1.5
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
153
990
1.76
7.56
1.6
1.8
pmol/l
417.2
14662092.2
0.80
120
798
(3048689) Calprotectin [Mass/mass] in Stool
86
468
1.99
7.30
2.4
2.1
ug/g
268.4
124.6
0.80
60
360
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
42
4.40
7.27
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
143
917
1.76
7.26
1.8
1.7
mg/l
1.0
1.3
0.82
101
711
(36660697) Celiac disease serology panel - Serum
60
290
2.20
6.95
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
99
3.04
6.80
2.1
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
24
5.52
6.80
2.3
2.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
279
2157
1.60
6.74
5.7
5.7
e9/l
0.2
0.2
0.87
238
1896
(3051593) INR in Capillary blood by Coagulation assay
12
21
5.82
6.61
2.9
11.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
41
4.25
6.59
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
46
4.01
6.48
2.3
2.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
81
3.19
6.39
2.6
2.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
274
2130
1.58
6.33
5.8
5.5
e9/l
1.9
1.9
0.02
242
1873
(3000330) Specific gravity of Urine by Test strip
51
240
2.24
6.30
6.2
4.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
15
34
4.51
6.27
1.0
1.2
—
81.8
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
37
151
2.56
6.25
7.3
5.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
62
318
2.07
6.17
1.8
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
177
1249
1.62
6.12
3.6
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
395
3361
1.64
6.08
8.0
7.4
u/l
80.2
78.5
0.22
360
3140
(3006315) Basophils [#/volume] in Blood
268
2087
1.56
6.05
5.8
5.5
e9/l
0.0
0.0
0.34
229
1808
(3001604) Monocytes [#/volume] in Blood
267
2078
1.56
6.04
5.6
5.4
e9/l
0.6
0.6
0.57
230
1792
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
136
2.60
5.98
1.7
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
440
3864
1.72
5.83
6.4
4.8
mu/l
2.0
1.9
0.30
384
3489
(3044889) 12 lead EKG panel
245
3031
0.65
5.63
4.4
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
290
2323
1.53
5.60
5.8
6.1
umol/l
10.6
11.6
1.40
272
2201
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
117
758
1.69
5.59
2.2
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
261
2.10
5.49
2.8
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
104
658
1.72
5.41
1.2
1.2
u/ml
9.3
12.1
0.20
30
246
(3024561) Albumin [Mass/volume] in Serum or Plasma
252
1971
1.52
5.36
4.1
4.3
g/l
35.0
35.0
0.04
218
1822
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
146
2.42
5.19
1.6
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
13
31
4.27
5.11
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
90
557
1.74
5.05
2.2
2.6
%
1.7
1.8
0.60
70
495
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
455
4078
1.70
5.04
6.0
4.8
mmol/l
6.1
6.0
1.21
386
3690
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
254
2008
1.50
5.04
4.1
4.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
118
2.54
4.96
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
51
3.41
4.92
1.2
1.1
iu/ml
1.0
12.4
—
5
9
(3019550) Sodium [Moles/volume] in Serum or Plasma
477
4350
1.77
4.72
23.4
18.1
mmol/l
139.5
139.6
0.27
465
4234
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
38
180
2.19
4.66
1.8
1.9
ug/l
1.2
3.5
0.71
25
156
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
85
532
1.71
4.57
6.2
7.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
477
4362
1.75
4.51
23.4
18.2
mmol/l
4.0
4.0
0.29
463
4242
(3005719) IgG [Mass/volume] in Serum or Plasma
56
311
1.89
4.48
2.7
2.8
g/l
10.3
10.5
0.11
46
283
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
22
82
2.75
4.47
1.2
1.2
e6/l
334.9
1470.0
0.41
17
68
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
82
2.75
4.47
1.0
1.1
e6/l
3.6
4.2
0.12
16
66
(3026008) Bacteria identified in Urine by Culture
193
1474
1.48
4.40
4.2
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
437
3922
1.58
4.30
17.5
14.5
ml/min/173m2
75.5
76.4
0.41
378
3255
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
84
2.69
4.28
1.0
1.2
—
1.0
—
0
6
(3020630) Protein [Mass/volume] in Serum or Plasma
67
400
1.77
4.25
1.9
3.2
g/l
66.2
66.5
0.08
55
361
(3001122) Ferritin [Mass/volume] in Serum or Plasma
230
1829
1.45
4.21
3.0
2.7
ug/l
129.4
132.4
0.09
199
1667
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
124
870
1.55
4.20
1.4
1.2
u/ml
3.3
1.8
0.32
22
225
(3037522) Nuclear Ab [Titer] in Serum
80
506
1.68
4.14
1.5
1.3
titre
668.0
544.2
0.20
20
114
(4027681)
10
23
4.41
4.10
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
298
3446
0.70
3.99
21.6
18.7
%
13.9
13.8
0.18
291
3381
(3022145) Colonoscopy Study observation
76
479
1.68
3.98
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
106
726
1.57
3.98
2.2
2.3
umol/l
11.6
12.6
0.72
94
665
(3004789) Transferrin [Mass/volume] in Serum or Plasma
98
660
1.59
3.95
2.2
2.3
g/l
2.4
2.3
0.29
85
606
(4010399)
54
309
1.83
3.95
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
276
2291
1.41
3.88
2.8
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
111
773
1.55
3.87
1.6
1.5
g/l
2.1
2.4
1.45
61
462
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
89
2.53
3.84
1.1
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
292
2451
1.41
3.84
7.2
8.9
e9/l
4.3
4.1
0.32
254
2146
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
433
3909
1.52
3.83
8.4
6.2
mmol/mol
41.5
40.4
1.68
376
3602
(3014271) Vancomycin [Susceptibility]
11
29
3.85
3.82
3.1
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
25
4.06
3.71
1.3
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
244
1.87
3.56
1.3
1.2
iu/ml
101.1
153.0
0.65
17
93
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
477
4420
1.63
3.56
13.1
10.6
u/l
24.9
24.6
0.11
453
4245
(40761511) CBC panel - Blood by Automated count
470
4340
1.60
3.56
22.2
14.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
46
3.10
3.55
1.5
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
6
10.09
3.50
1.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
178
1389
1.42
3.47
4.6
3.9
mg/mmol
10.9
8.2
0.23
103
867
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
697
1.53
3.46
1.3
1.2
iu/ml
22.5
37.7
1.29
28
232
(3045142) Bone marrow Pathology biopsy report
14
47
3.03
3.43
1.6
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
91
623
1.55
3.41
2.3
2.3
%
19.0
21.9
1.29
76
534
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
431
3917
1.48
3.41
5.0
4.0
mmol/l
1.3
1.3
0.81
378
3537
(40768804) Tissue Pathology biopsy report
214
1734
1.39
3.32
2.5
2.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
68
437
1.64
3.32
2.9
3.2
mmol/l
3.0
2.1
1.29
57
348
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
366
1.69
3.30
3.0
3.7
ng/l
68.7
86.9
1.19
45
319
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
192
1.94
3.28
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
43
3.07
3.27
1.5
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
66
2.63
3.24
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
38
3.21
3.23
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
53
323
1.71
3.16
4.2
3.6
%
0.8
0.5
0.44
21
81
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
20
4.56
3.12
1.8
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
20
4.56
3.12
1.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
20
4.56
3.12
1.8
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
32
167
1.97
3.11
1.6
2.1
u/l
33.6
41.7
1.46
27
147
(3049717) Cytology report of Urine Cyto stain
35
189
1.91
3.09
2.7
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
89
621
1.52
3.06
28.2
25.5
inr
1.8
1.3
—
8
71
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
39
220
1.83
3.02
2.8
3.1
pmol/l
4.2
4.4
0.53
29
186
(3003181) Sodium [Moles/volume] in Urine
19
81
2.39
3.02
1.5
1.3
mmol/l
57.2
58.4
0.06
13
69
(3021440) Promyelocytes/100 leukocytes in Blood
55
345
1.66
2.96
4.1
3.7
%
0.0
0.1
1.06
26
106
(40768797) Stomach Pathology biopsy report
88
617
1.51
2.96
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
30
3.38
2.92
1.1
1.2
u/ml
0.0
0.1
—
5
17
(3012095) Magnesium [Moles/volume] in Serum or Plasma
100
723
1.47
2.90
2.2
3.1
mmol/l
0.8
0.8
0.27
86
675
(3048879) Bone marrow aspiration report
7
13
5.44
2.87
3.3
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
83
579
1.51
2.86
4.8
4.7
mmol/l
1.0
1.0
0.06
73
520
(3007461) Platelets [#/volume] in Blood
487
4582
1.59
2.85
30.0
22.6
e9/l
248.3
246.3
0.24
479
4447
(3024731) MCV [Entitic volume]
487
4582
1.59
2.85
29.9
22.6
fl
91.3
91.4
0.26
482
4498
(3035941) MCH [Entitic mass]
487
4583
1.59
2.84
29.8
22.5
pg
30.3
30.3
0.23
482
4499
(3026361) Erythrocytes [#/volume] in Blood
487
4584
1.59
2.82
30.0
22.6
e12/l
4.4
4.4
0.46
479
4435
(3010813) Leukocytes [#/volume] in Blood
487
4584
1.59
2.82
30.1
22.7
e9/l
7.0
6.8
1.03
479
4437
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
31
3.27
2.78
1.6
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
487
4587
1.58
2.78
30.2
22.7
g/l
132.5
133.2
0.48
482
4502
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
14
5.05
2.73
1.3
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
247
2096
1.33
2.69
5.2
3.9
estimate
0.0
0.0
0.00
39
398
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
164
1310
1.36
2.68
5.1
5.1
ug/l
3.7
2.6
0.51
138
1145
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
25
3.64
2.58
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
25
3.64
2.58
1.8
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
25
3.64
2.58
1.8
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
25
3.64
2.58
1.8
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
56
367
1.59
2.55
4.0
3.6
%
0.8
0.9
0.15
26
116
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
141
1108
1.37
2.54
3.0
2.7
umol/l
12261.7
8044.1
0.30
120
945
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
129
1.98
2.54
1.5
1.5
ug/g
223.4
275.8
0.73
17
79
(3009261) Glucose [Presence] in Urine by Test strip
250
2141
1.31
2.50
5.1
4.0
estimate
0.0
0.0
0.00
37
390
(3041096) Erythrocytes [Presence] in Urine by Automated
146
1162
1.35
2.42
4.7
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
168
1.83
2.42
2.3
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
246
2109
1.30
2.41
7.7
5.4
estimate
0.0
0.0
0.00
39
390
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
22
111
2.02
2.39
1.1
1.1
—
10.6
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
8
6.29
2.37
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
50
325
1.59
2.37
4.1
3.7
%
0.0
1.1
0.53
23
89
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
46
2.64
2.37
3.8
2.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
17
4.16
2.36
1.6
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
73
518
1.47
2.33
4.4
3.9
u/l
238.9
240.9
0.07
67
490
(3022621) pH of Urine by Test strip
45
288
1.61
2.28
4.5
3.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
66
2.31
2.26
2.1
2.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
29
3.14
2.23
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
29
3.14
2.23
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
9
5.59
2.22
1.2
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
114
888
1.36
2.16
3.9
2.9
mosm/kgh2o
555.2
557.2
0.03
102
761
(3018418) pH of Serum or Plasma
108
1370
0.74
2.15
4.0
3.9
ph
7.4
7.4
0.87
29
257
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
95
2.04
2.13
4.2
4.4
mg/l
29.6
31.9
—
10
62
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
131
1.87
2.11
1.5
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
10
5.03
2.07
3.2
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
163
1346
1.30
2.06
3.7
3.1
mmol/l
6.4
7.1
1.23
125
1116
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
44
2.53
2.02
1.0
1.3
nmol/l
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
158
1305
1.30
1.98
3.6
3.2
mg/l
52.5
297.9
1.53
83
837
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
434
4064
1.33
1.97
5.7
4.5
mmol/l
1.4
1.5
2.89
380
3702
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
11
4.58
1.94
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
150
1.77
1.94
3.0
3.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
45
2.47
1.94
1.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
33
2.76
1.94
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
54
376
1.48
1.92
5.5
6.3
mmol/l
10.7
10.4
0.09
48
351
(3009542) Hematocrit [Volume Fraction] of Blood
398
3690
1.29
1.90
18.2
16.6
%
37.1
39.1
1.75
209
2482
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
436
4094
1.32
1.88
5.5
4.5
mmol/l
4.5
4.6
0.84
383
3755
(3030981) Hyaline casts [#/volume] in Urine by Automated count
38
246
1.59
1.87
2.7
3.0
e6/l
0.2
0.2
0.04
38
240
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
28
2.88
1.87
1.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
1343
1.28
1.86
2.6
3.0
u/l
30.9
32.2
0.29
146
1280
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
192
1639
1.26
1.84
5.7
4.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.19
1.82
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
87
1.98
1.81
3.9
2.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
80
2.03
1.81
2.3
2.3
%
16.6
15.2
—
8
34
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
444
4191
1.32
1.76
5.8
5.1
mmol/l
2.6
2.7
0.38
386
3818
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
18
3.36
1.75
1.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
54
2.25
1.75
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
48
336
1.47
1.68
2.0
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
70
911
0.73
1.63
2.8
3.0
mmol/l
2.4
2.5
0.48
59
787
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
14
3.59
1.62
2.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
240
1.54
1.59
1.2
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
224
1.55
1.58
1.4
2.0
g/l
1.7
1.5
0.73
28
195
(3021901) Oxygen saturation in Capillary blood
15
78
1.95
1.55
1.5
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
183
1581
1.24
1.54
2.4
3.2
mmol/l
2.3
2.4
0.35
125
1347
(4034850)
6
143
0.41
1.54
9.0
11.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
259
1.50
1.53
1.4
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
15
3.35
1.52
5.6
4.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
51
2.18
1.51
1.6
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
16
3.14
1.44
2.0
1.3
nmol/l
140.0
114.3
—
5
9
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
189
1.56
1.43
1.6
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
189
1.56
1.43
1.6
2.5
g/l
3.5
3.7
0.20
14
133
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
189
1.56
1.43
1.6
2.5
g/l
7.4
7.5
0.22
18
138
(1002224) Polysomnography panel
21
126
1.69
1.42
1.1
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.8
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.8
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
112
1.72
1.37
1.1
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
182
1589
1.22
1.36
3.9
3.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
17
2.96
1.36
3.8
2.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(4211845)
5
17
2.96
1.36
5.6
4.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
17
2.96
1.36
1.2
1.4
nmol/l
139.0
132.1
—
5
17
(3012441) Differential panel - Pleural fluid
9
42
2.16
1.34
1.1
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
83
1.83
1.32
1.2
1.2
—
—
—
0
0
(4062490)
8
34
2.37
1.29
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
9
44
2.06
1.27
1.2
1.3
u/l
462.3
316.9
—
9
44
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
77
1.84
1.26
1.6
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
92
1.76
1.26
1.2
1.8
e6/l
1116.1
24750.9
—
9
67
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
16
92
1.76
1.26
3.0
3.5
u/ml
23.9
424.3
0.89
16
87
(40761535) Cells panel - Urine sediment
48
357
1.38
1.25
3.4
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
281
1.42
1.22
1.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
36
256
1.43
1.21
2.1
1.7
g/l
1.0
1.4
1.08
29
235
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
57
1.95
1.17
1.2
1.2
—
—
—
0
0
(4094501)
17
102
1.69
1.17
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
196
0.55
1.14
1.1
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
79
642
1.27
1.13
1.6
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
87
716
1.26
1.13
3.5
3.0
e6/l
2.8
2.4
0.19
58
393
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
30
2.35
1.12
1.3
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
176
1.50
1.12
1.7
2.6
g/l
2.8
3.2
1.03
15
135
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
383
1.34
1.10
1.5
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
253
0.62
1.07
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
51
395
1.32
1.05
1.9
2.4
ug/l
4.4
5.4
0.41
34
348
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
34
2.07
1.03
2.6
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
107
0.46
1.02
1.0
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
115
1.58
1.00
1.9
2.6
ug/min
44.4
85.0
—
9
63
(3000494) Fungus identified in Specimen by Culture
64
517
1.27
0.98
1.8
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.6
—
10.6
—
0
16
(40768806) Pleura Pathology biopsy report
10
54
1.87
0.97
1.7
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
133
1.52
0.95
1.5
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
51
1.78
0.95
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
54
430
1.28
0.93
2.5
2.1
g/l
0.2
0.2
0.07
49
402
(40758558) Short blood count panel - Blood
92
1077
0.82
0.93
5.0
6.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
52
1.74
0.92
1.9
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
16
102
1.59
0.91
1.5
2.2
kpa
7.5
7.8
0.28
16
90
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
103
1.57
0.88
1.6
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
87
1.63
0.88
3.1
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
389
1.29
0.87
1.5
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
64
1.73
0.86
2.5
2.4
—
777.4
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
453
1.26
0.86
1.5
1.5
—
—
—
0
0
(4306422)
8
46
1.75
0.83
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
105
1.54
0.82
1.5
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
81
1.62
0.82
2.2
1.9
u/l
12.8
5971.3
—
6
25
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
23
164
1.42
0.81
1.7
2.8
g/l
1.2
0.9
0.11
17
139
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
98
1.55
0.79
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
67
1.66
0.75
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
334
0.74
0.75
1.8
2.6
ml/min/173m2
58.0
62.6
—
10
134
(3018095) Leukocytes [#/volume] in Urine
171
1558
1.14
0.73
4.4
3.9
e6/l
45.7
96.1
1.85
116
1117
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
177
1.37
0.72
1.6
2.6
g/l
10.0
10.5
0.20
17
147
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
40
1.76
0.71
1.4
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
58
1.56
0.70
2.6
2.0
%
87.8
89.7
—
9
58
(3027944) Amphetamines [Presence] in Urine
5
93
0.53
0.67
1.8
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
137
1.40
0.65
1.7
2.3
u/ml
0.5
0.4
—
9
78
(3000850) Epithelial cells [#/volume] in Urine
81
927
0.85
0.65
2.7
2.7
e6/l
4.4
5.9
1.06
72
832
(3035637) Corticotropin [Mass/volume] in Plasma
7
44
1.60
0.65
1.9
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
62
526
1.20
0.65
1.6
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
127
0.62
0.64
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
20
146
1.38
0.64
1.4
1.9
s
19.5
21.8
2.05
15
129
(42529406) Shigella sp [Presence] in Stool by Culture
8
130
0.61
0.64
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
131
0.60
0.64
3.9
3.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
71
1.56
0.62
1.5
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
71
1.56
0.62
1.2
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
59
501
1.20
0.62
2.1
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
106
1183
0.87
0.61
3.7
3.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
51
1.58
0.60
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
11.4
—
901.8
—
0
21
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
16.9
—
1800.9
—
0
21
(3015183) Erythrocyte sedimentation rate
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
89
1.47
0.58
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
211
1.29
0.58
1.8
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
54
1.49
0.57
1.1
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
36
1.67
0.57
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
36
1.67
0.57
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
87
0.57
0.56
3.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
545
0.83
0.56
2.2
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
37
1.63
0.55
1.2
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
93
1038
0.87
0.55
4.2
4.4
%
23.6
21.5
0.49
53
504
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
126
0.63
0.55
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
60
1.51
0.54
1.1
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
63
550
1.16
0.50
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
67
588
1.16
0.50
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
93
1.41
0.48
1.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
76
1.46
0.48
1.9
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
80
893
0.88
0.48
3.7
4.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
227
1.25
0.47
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
119
0.67
0.46
1.9
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
176
1871
0.91
0.44
11.2
9.4
e9/l
0.0
0.0
0.25
151
1536
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
95
864
1.12
0.43
4.9
3.8
ng/l
107.8
310.0
1.32
70
719
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
413
0.84
0.43
2.7
2.3
u/l
116.2
31.9
0.51
28
343
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
520
1.15
0.43
2.9
4.1
ug/l
3.4
34.3
1.29
43
439
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
3.0
—
56.2
—
0
11
(3000492) Spirometry study
42
360
1.18
0.43
1.4
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
92
0.65
0.42
2.7
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
92
0.65
0.42
2.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
93
0.64
0.42
2.7
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
32
1.57
0.42
1.0
1.6
—
275.0
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
32
1.57
0.42
1.8
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.4
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
2.4
—
0
6
(4198724)
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
60
1.34
0.40
3.3
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
251
1.21
0.40
1.2
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
48
547
0.87
0.40
2.2
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
115
1.31
0.39
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
19
152
1.26
0.37
2.8
3.8
—
1.5
—
0
13
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
125
0.72
0.35
1.7
1.3
iu/l
26.3
28.8
—
9
109
(3017446) Testosterone [Moles/volume] in Serum or Plasma
27
227
1.20
0.35
3.0
2.1
nmol/l
11.5
13.1
0.34
21
197
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
19
154
1.24
0.34
1.8
2.7
g/l
39.1
37.4
0.33
12
129
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
82
1.35
0.34
1.0
1.4
miu/ml
225.2
263.8
—
5
45
(40768443) Skin Pathology biopsy report
23
191
1.21
0.34
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
52
1.35
0.31
1.7
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
96
0.73
0.31
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
96
0.73
0.31
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
54
487
1.12
0.30
2.4
2.5
umol/l
4.7
9.6
5.45
45
413
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
83
768
1.10
0.29
3.4
2.8
e6/l
1.0
1.1
0.07
52
440
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
66
1.22
0.27
1.4
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
12
95
1.27
0.26
1.5
1.2
—
46.0
—
0
5
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
591
0.90
0.26
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
181
0.82
0.25
1.1
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
1.3
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
306
0.88
0.23
3.3
3.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
106
1.23
0.23
1.4
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
168
0.83
0.23
1.3
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
141
1348
1.06
0.23
3.7
3.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.4
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
92
0.76
0.22
1.3
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
43
1.16
0.21
1.6
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
99
1043
0.94
0.21
1.5
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
14
0.00
0.20
0.0
2.3
—
15.5
—
0
14
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
231
1.13
0.20
5.8
8.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
111
1162
0.94
0.19
5.2
4.2
estimate
0.0
0.0
0.00
37
380
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
109
1.20
0.18
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
60
1.17
0.18
1.1
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
61
1.15
0.17
1.7
2.1
pg
33.3
33.2
—
7
61
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
69
1.16
0.16
1.9
3.1
e9/l
3.8
4.5
—
8
69
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
72
1.11
0.16
2.0
3.7
%
61.3
58.7
—
8
72
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
73
1.10
0.15
1.3
1.2
—
42.1
—
0
7
(40768800) Prostate Pathology biopsy report
6
79
0.76
0.15
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
81
1.11
0.15
1.7
1.5
mu/l
308.0
312.2
—
9
71
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
116
1119
1.05
0.14
1.7
1.6
mmol/l
1.4
1.3
0.19
98
921
(3033658) Prothrombin time (PT) actual/Normal
104
1079
0.96
0.14
4.0
3.7
%
87.0
88.6
0.26
99
1052
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
100
0.80
0.13
1.9
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
110
0.82
0.13
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
355
1.08
0.13
5.4
3.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
127
0.86
0.12
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
127
0.86
0.12
1.5
1.3
—
—
—
0
0
(3010421) pH of Blood
13
114
1.14
0.12
6.7
3.1
ph
7.4
7.4
0.29
13
96
(3016502) Oxygen saturation in Arterial blood
49
467
1.05
0.10
4.1
6.6
%
94.2
95.3
0.38
44
450
(3028707) Methadone [Presence] in Urine by Screen method
5
44
1.14
0.10
2.6
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
68
1.03
0.08
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
41
392
1.05
0.07
1.5
1.7
%
1.6
1.5
0.12
35
335
(3019230) Fractional oxyhemoglobin in Venous blood
6
75
0.80
0.07
1.3
1.9
%
56.3
59.3
—
6
75
(3030467) Casts [#/volume] in Urine by Automated count
122
1245
0.97
0.07
3.7
3.2
e6/l
0.5
0.5
0.00
95
935
(3019150) Specific gravity of Urine by Refractometry
93
951
0.97
0.06
5.9
4.3
kg/l
1.0
1.0
0.04
25
142
(3020891) Body temperature
16
172
0.93
0.06
1.6
3.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
476
0.96
0.06
5.0
3.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
21
198
1.06
0.05
1.0
1.1
—
106.2
—
0
5
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
74
756
0.98
0.05
3.4
3.0
ug/l
1.0
0.8
0.42
57
510
(3003396) Base excess in Arterial blood by calculation
51
524
0.97
0.04
4.2
6.4
mmol/l
1.7
1.3
0.34
32
411
(3011397) Hemoglobin [Presence] in Urine by Test strip
98
967
1.02
0.03
4.7
3.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
108
0.92
0.03
2.3
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
38
370
1.03
0.03
4.3
7.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
137
1358
1.01
0.02
3.8
3.3
e6/l
85.6
116.5
0.17
108
1046
(4035726)
41
401
1.02
0.02
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
258
0.97
0.02
1.8
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
113
1.06
0.02
3.5
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
97
1.03
0.00
1.6
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
97
1.03
0.00
2.1
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
273
0.99
0.00
1.4
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
283
0.99
0.00
1.8
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
98
0.92
0.00
1.2
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.8
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
58.3
—
0
5
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
1.7
—
2067.6
—
0
9
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
55
0.91
0.00
2.0
4.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
51
0.98
0.00
1.2
2.2
u/ml
86.3
78.9
—
5
51
(3039443) Prostate specific Ag panel - Serum or Plasma
7
72
0.97
0.00
1.4
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
26.0
—
0
8
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
77
0.91
0.00
1.6
1.7
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
17.4
—
0
9
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
9.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
11.6
—
6.5
—
0
7
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
58
0.86
0.00
3.2
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
10.7
—
0
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_VERTIGOCENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VERTIGOCENT | 1.227 [1.11, 1.36] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 1126 out of 2537 females with H8_VERTIGOCENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VERTIGOCENT | 1.266 [1.1, 1.45] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 670 out of 1498 males with H8_VERTIGOCENT died.
Mortality risk
Mortality risk for people of age
years, who have H8_VERTIGOCENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.097% | 0.29% |
| 5 | 0.606% | 1.603% |
| 10 | 1.518% | 4.157% |
| 15 | 2.797% | 7.829% |
| 20 | 4.847% | 13.0% |
Relationships between endpoints
↥Index endpoint: H8_VERTIGOCENT – Vertigo of central origin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data